logo
Select company
Select metric
3.74Cash Ratio
VS
Market
90
Sector
81
Industry
72
History
55
$ 3.41Close
$ 1.66 - $ 3.9 52-Week Range
Ticker Information

Ticker

NUVB

Company Name

NUVATION BIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSE

NUVATION BIO INC - Cash Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NUVB - Cash Ratio Historical data
DateCash and EquivalentsCash RatioCurrent Liabilities
6/30/2025$ 247.97M3.74$ 66.36M
3/31/2025$ 47.98M0.91$ 52.77M
12/31/2024$ 35.72M0.61$ 58.24M
9/30/2024$ 30.04M0.51$ 59.03M
6/30/2024$ 34.28M0.67$ 51.09M
3/31/2024$ 34.51M2.19$ 15.76M
12/31/2023$ 42.65M3.05$ 13.97M
9/30/2023$ 24.39M1.51$ 16.14M
6/30/2023$ 50.06M3.73$ 13.41M
3/31/2023$ 30.07M2.4$ 12.55M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NUVATION BIO INC's latest trailing twelve months (TTM) Cash Ratio stands at 1.38.
  • Over the past 5 years, NUVATION BIO INC's average Cash Ratio has been 9.74.
  • The median Cash Ratio for NUVATION BIO INC during this period was 3.73
  • NUVATION BIO INC reached its highest Cash Ratio over the past 5 years at 63.97.
  • The lowest Cash Ratio recorded by NUVATION BIO INC in the same timeframe 0.51

NUVATION BIO INC's Cash Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash Ratio Benchmarks
CompanyCash Ratio
QURE : UNIQURE NV 6.2ZBIO : ZENAS BIOPHARMA INC 0.83ABUS : ARBUTUS BIOPHARMA CORP 7.45IMNM : IMMUNOME INC 6.3VIR : VIR BIOTECHNOLOGY INC 2.85TSHA : TAYSHA GENE THERAPIES INC 12.44CAPR : CAPRICOR THERAPEUTICS INC 0.82RLAY : RELAY THERAPEUTICS INC 3.57BCYC : BICYCLE THERAPEUTICS PLC 9.32TNGX : TANGO THERAPEUTICS INC 0.99

Definition of Cash Ratio

[Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for NUVATION BIO INC is calculated as follows: CashnEq [ $ 1.34M ] / LiabilitesC [ $ 974.03K ]
(=) Cash Ratio [ 1.38 ]

NUVB - Cash Ratio, Last 5 years

0.51

Minimum

Sep 30, 2024

63.97

Maximum

Mar 31, 2021

9.74

Average

3.73

Median

Cash Ratio Benchmark Analysis

The chart above depicts the distribution of Cash Ratio for companies in the Total Stock Market. The average Cash Ratio of the companies is 0.62 with a standard deviation of 0.63.
The following table provides additional summary stats:
Cash Ratio in the Market:
filtered constituents3.13K
min0
max2.69
average0.62
median0.39
std0.63